Special acknowledgement is made to Professor R.C. Moreau, former President, French Pharmacopoeia Commission, Paris, France, who prepared this Annex, and to Mr R.B. Trigg, Secretary, British Approved Names (BAN) Committee, London, England, for his valuable contribution.